ETD-001

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameETD-001
Drug Alias NameETD-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpithelial sodium channel blockers
TargetsEpithelial sodium channel
Therapy Area/IndicationsCicatrixCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyGermanyUnited Kingdom +[5
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEnterprise Therapeutics Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCicatrixCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A